Data as of Q4 2025 (Dec 31, 2025)

5AM Venture Management, LLC

โ€ขCIK: 1799883โ€ขFiling: Q4 2025

**5AM Venture Management, LLC** is a venture-focused fund managing $318M across 21 positions. The portfolio exhibits significant concentration in key technology and growth names, with top holdings including TRDA at $41.7M and CAMP at $36.0M. Further substantial allocations are directed toward TYRA ($27.1M), VRDN ($22.9M), and BLK ($22.1M). This structure indicates a conviction-driven, high-conviction approach within the venture landscape.

Total AUM
$318.1M
QoQ Performance
+16.5%
Positions
21
Top 10 Concentration
73.5%
Latest Filing
Q4 2025

Top Holdings Allocation

TRDA
CAMP
TYRA
VRDN
PHAR
ERAS
EYPT
MPLT
TRDA13.1%
CAMP11.3%
TYRA8.5%
VRDN7.2%
PHARVARIS7.0%
ERAS6.3%
EYPT6.0%
MPLT5.2%

๐Ÿ“ˆ Biggest Buys

MPLT
MAPLIGHT THERAPEUTICS INC
NEW
5.2% of portfolio
ZNTL
ZENTALIS PHARMACEUTICALS INC
+705.7%
1.7% of portfolio
TARA
PROTARA THERAPEUTICS INC
+71.2%
2.3% of portfolio
BHVN
BIOHAVEN LTD
+54.3%
2.6% of portfolio
TYRA
TYRA BIOSCIENCES INC
+9.6%
8.5% of portfolio

๐Ÿ“‰ Biggest Sells

CNTA
CENTESSA PHARMACEUTICALS PLC
-14.7%
4.6% of portfolio
TRDA
ENTRADA THERAPEUTICS INC
-4.7%
13.1% of portfolio

Sector Breakdown

Other100.0%

๐Ÿšช Exited Positionssold since Q3 2025

DNTH
DIANTHUS THERAPEUTICS INC
SOLD
$14.4M
PRAX
PRAXIS PRECISION MEDICINES I
SOLD
$9.0M
ALEC
ALECTOR INC
SOLD
$2.9M
โ€”
ADVERUM BIOTECHNOLOGIES INC
SOLD
$2.5M
MRSN
MERSANA THERAPEUTICS INC
SOLD
$405.1K

Changes from Q3 2025

NEW1 new position
โ†‘6 increased
โ†“2 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023